<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE rss [<!ENTITY % HTMLlat1 PUBLIC "-//W3C//ENTITIES Latin 1 for XHTML//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml-lat1.ent">]>
<rss version="0.92" xml:base="http://www.yakat.com/coloncancer">
<channel>
 <title>Colon cancer news - Colon cancer news</title>
 <link>http://www.yakat.com/coloncancer</link>
 <description>Colon cancer news</description>
 <language>en</language>
<item>
 <title>Earnings: Genentech, Harley Davidson, Circuit City</title>
 <link>http://www.yakat.com/coloncancer/node/11522</link>
 <description>...  FOXNews.com - Earnings: Gannett, Genentech, Harley Davidson, Circuit City - Business And Money  Financial News&lt;/p&gt;&lt;p&gt;NEW YORK (Reuters) - Gannett Co. Inc. (GCI ) Wednesday said first-quarter earnings ...</description>
 <pubDate>Wed, 12 Apr 2006 11:00:16 -0400</pubDate>
</item>
<item>
 <title>Take advantage of fresh asparagus</title>
 <link>http://www.yakat.com/coloncancer/node/11521</link>
 <description>...  ...</description>
 <pubDate>Wed, 12 Apr 2006 11:00:12 -0400</pubDate>
</item>
<item>
 <title>Tea parties will help fight ovarian cancer</title>
 <link>http://www.yakat.com/coloncancer/node/11520</link>
 <description>...  Tea parties will help fight ovarian cancer Recent News Archives Web&lt;/p&gt;&lt;p&gt;Back to Home &gt; Living &gt; Wednesday, Apr 12, 2006 Health Posted on Tue, Apr. 11, 2006 email this print this reprint or license  ...</description>
 <pubDate>Wed, 12 Apr 2006 11:00:05 -0400</pubDate>
</item>
<item>
 <title>Genentech quarterly profit surges</title>
 <link>http://www.yakat.com/coloncancer/node/11519</link>
 <description>...  ...</description>
 <pubDate>Wed, 12 Apr 2006 11:00:04 -0400</pubDate>
</item>
<item>
 <title>Detection of Resectable Recurrence of Colorectal Cancer Is Not ...</title>
 <link>http://www.yakat.com/coloncancer/node/11518</link>
 <description>... &lt;p&gt;NEW YORK APR 11, 2006 (Reuters Health) - Routine pelvic surveillance by magnetic resonance imaging (MRI) after a curative resection of colorectal cancer is not justified, based on results of a stud ...</description>
 <pubDate>Wed, 12 Apr 2006 10:00:33 -0400</pubDate>
</item>
<item>
 <title>BEFORE THE BELL: Genentech Down Despite Strong 1Q Results</title>
 <link>http://www.yakat.com/coloncancer/node/11517</link>
 <description>... &lt;p&gt;To continue reading the complete article, login or register ...</description>
 <pubDate>Wed, 12 Apr 2006 10:00:30 -0400</pubDate>
</item>
<item>
 <title>Genentech profit up on medicine sales</title>
 <link>http://www.yakat.com/coloncancer/node/11516</link>
 <description>... colon cancer patients and accounted for $398 million in U.S. sales in the first quarter, a 96 percent increase over the previous year's quarter of $203 million.&lt;/p&gt;&lt;p&gt;The company also said Tuesday it ...</description>
 <pubDate>Wed, 12 Apr 2006 10:00:25 -0400</pubDate>
</item>
<item>
 <title>Avastin Filed in US for Treatment of Most Common Form of Lung ...</title>
 <link>http://www.yakat.com/coloncancer/node/11514</link>
 <description>...  PharmaLive: Avastin Filed in US for Treatment of Most Common Form of Lung Cancer &lt;/p&gt;&lt;p&gt;The supplemental Biologics License Application (sBLA) has been submitted to the US Food and Drug Administration ...</description>
 <pubDate>Wed, 12 Apr 2006 09:00:06 -0400</pubDate>
</item>
<item>
 <title>COMMENTARY: Charisse Strawberry turns her mess into a message</title>
 <link>http://www.yakat.com/coloncancer/node/11515</link>
 <description>... colon cancer and one ugly personal failing after another.&lt;/p&gt;&lt;p&gt;But during the process, she learned addiction is like a tornado - it absorbs and destroys everything in its path.&lt;/p&gt;&lt;p&gt;And always in th ...</description>
 <pubDate>Wed, 12 Apr 2006 09:00:06 -0400</pubDate>
</item>
<item>
 <title>InNexus and Affimed form anticancer collaboration</title>
 <link>http://www.yakat.com/coloncancer/node/11512</link>
 <description>...  InNexus and Affimed form anticancer collaboration - Pharmaceutical Business Review  ...</description>
 <pubDate>Wed, 12 Apr 2006 07:00:07 -0400</pubDate>
</item>
<item>
 <title>Array receives milestone payment in AstraZeneca collaboration</title>
 <link>http://www.yakat.com/coloncancer/node/11513</link>
 <description>...  Array receives milestone payment in AstraZeneca collaboration - Pharmaceutical Business Review ...</description>
 <pubDate>Wed, 12 Apr 2006 07:00:07 -0400</pubDate>
</item>
<item>
 <title>Genentech boosts profit</title>
 <link>http://www.yakat.com/coloncancer/node/11510</link>
 <description>... &lt;p&gt;"It looks as though the non-Hodgkin's lymphoma market is really tapped out," Porges said in a telephone interview.&lt;/p&gt;&lt;p&gt;The company said Tuesday that earnings per share excluding some items will  ...</description>
 <pubDate>Wed, 12 Apr 2006 07:00:06 -0400</pubDate>
</item>
<item>
 <title>Pizarro: Mayoral hopefuls united behind arts</title>
 <link>http://www.yakat.com/coloncancer/node/11511</link>
 <description>...  Pizarro: Mayoral hopefuls united behind arts Recent News Archives Web&lt;/p&gt;&lt;p&gt;Back to Home &gt; Opinion &gt; Wednesday, Apr 12, 2006 Columnists Posted on Wed, Apr. 12, 2006 email this print this reprint or l ...</description>
 <pubDate>Wed, 12 Apr 2006 07:00:06 -0400</pubDate>
</item>
<item>
 <title>Mal Karman&amp;#39;s conspiracy thriller proved prophetic. No time for &amp;#39;I ...</title>
 <link>http://www.yakat.com/coloncancer/node/11509</link>
 <description>... &lt;p&gt;Your car donation helps build homes for families in need.&lt;/p&gt;&lt;p&gt;Back To Top San Francisco Chronicle Sections Datebook Commentary Food Sports News Bay Area Home&amp;Garden Business 2006 San Francisco Ch ...</description>
 <pubDate>Wed, 12 Apr 2006 07:00:04 -0400</pubDate>
</item>
<item>
 <title>Biotech pioneer prospers</title>
 <link>http://www.yakat.com/coloncancer/node/11508</link>
 <description>... &lt;p&gt;Back To Top San Francisco Chronicle Sections Datebook Commentary Food Sports News Bay Area Home&amp;Garden Business 2006 San Francisco Chronicle  ...</description>
 <pubDate>Wed, 12 Apr 2006 07:00:03 -0400</pubDate>
</item>
</channel>
</rss>
